The tropism of the human T-cell leukemia virus type 1 (HTLV-1) for the cells of monocyte-macrophage lineage was evaluated by the coculture of blood monocyte-derived macrophages, with irradiated cells of HTLV-1 producing cell lines MT2 or CSl/PL. The susceptibility to HTLV-1 was assessed by the detection of viral DNA using the polymerase chain reaction method. HTLV-1 gene expression in the cells was detected using in situ hybridization and by immunofluorescent staining of viral antigen. The presence of type C
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virus-like particles detected by electron microscopy and the ability to infect normal cord blood lymphocytes demonstrated that the infected macrophages produced infectious virus. These results indicate that human macrophages are susceptible in vitro to productive HTLV-1 infection, and thus might be involved in the pathogenesis of HTLV-1 -related diseases.
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blood mononuclear cells (PBMC) ." The purity of the monocyte fractions was more than 98% as analyzed by morphology (MayGriinwald-Giemsa) and flow cytometry after immunostaining with the anti-CDI I b/CR3 monoclonal antibody IOM 1 b (Immunotech, Marseilles, France). Cultures were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS; Boehringer Mannheim, Mannheim, Germany), 20 mmol/L ~-glutamine, and antibiotics (penicillin/streptomycin/neomycin) (medium A). Monocytes were placed in 150 X 100 mm plastic flasks (Falcon, Mountain View, CA) and in tissue culture chamber/slides (Lab-Teck; Miles Scientific, Naperville, IL) for immunofluorescence analysis. Cells were cultured at 37°C in a humidified atmosphere containing 5% COz. Monocyte adherence and differentiation in macrophages were obtained after 5 to 8 days of culture as proved by phase contrast microscopy examination and surface antigen labeling as described elsewhere.I6 Cultures were examined daily and half of the medium changed twice a week.
Cell line cultures. The HTLV-1-producing cell lines, MT2" and C91/PL (kindly provided by Dr A. Gessain, Institut Pasteur, Paris, France), were used as sources of virus, and the HTLV-1 -negative Tcell line MOLT4 was used as the negative control. All cell lines were cultured at an initial concentration of IO5 cells/mL in medium A and passaged every 3 days.
MT2 or C91/PL cells, and MOLT4 cells as a negative control, were harvested and gamma irradiated (90 Gy) to prevent their growth, as described in previous report^.^-^^^^ Cells were washed to eliminate free radicals and toxics induced by radiations. Seven days after monocyte adherence, the macrophages were cocultured for 72 hours with irradiated cells at a 1: 1 ratio, and subsequently extensively washed three times. Cultures were then fed every 3 days and washed once a week or more if irradiated cell debris were detectable. Macrophage cultures were maintained for more than 30 days after infection and examined daily with an inverted phase contrast microscope (Zeiss, Oberkochen, Germany).
Viral transmission from infected macrophages to permissive cells. At day 15 postinfection, HTLV-I-infected macrophages were overlayed for 48 hours with normal cord blood lymphocytes (CBL) previously activated with 1/500 phytohemagglutinin A (pHA) and grown in medium A supplemented with 10% interleukin-2 (IL-2; Boehringer Mannheim) (medium B). The CBL were then harvested, cultured in separate flasks in medium B, and assayed for HTLV-1 transmission.
At day 15 postinfection, HTLV-1 antigen expression was assessed by the indirect immunofluorescence technique. Macrophages were fixed for 10 minutes at -20°C in ethanol, washed in phosphate-buffered saline (PBS), and incubated for 30 minutes at room temperature with 1/10 AB+ human serum to eliminate nonspecific antibody binding. Cells were then washed and incubated for 30 minutes at room temperature with a 1/10 dilution of rabbit polyclonal anti-Env HTLV-I antibody, obtained
HTLV-I infection of macrophages.
Immunofluorescence assays. Polwnerase chain reaction (PCR) analwis of proviral DNA seqzrenca. To amplify HTLV-I sequences in the macrophage DNA, oligonucleotide primer pairs from the HTLV-I-env region (TV3, bases 5662 to 5685; TV4, bases 6 I06 to 6 130) were used as described Scanning of the autoradiography allowed a semiquantitative assay and an estimation of the percentage of infected cells.
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In situ hybridization (ISH) detection of HTLV-I RNA in macrophage.s. ISH was performed at day I5 postinfection using C9 I /PL cells as source of virus. A negative strand RNA probe allowing the detection ofthe messenger-and/or viral-positive RNA was transcribed in the presence of (n-"S) UTP with the Sp6 RNA polymerase from S S p 6 plasmid (kindly provided by B. Guillemain, Inserm U. 328, Bordeaux. France). The latter plasmid was pGEMI plasmid con- mmol/L dithiotheitrol. and 6 X IOs dpm of the probe after the slides had been covered with acetylated sterile glass coverslips sealed with rubber cement. After hybridization, coverslips were removed by dipping the slides in 2X SSC ( I X SSC: I50 mmol/L NaCI, I5 mmol/L sodium citrate) and the cells were extensively washed before dehydration in graded ethanol solutions, air dried. and dipped in a solution of Kodak NTB-2 nuclear track emulsion (Eastman Kodak, Rochester. NY) diluted 1:2 with distilled water. They were left in the dark at 4°C for exposure (2 to IO days) and then developed with Kodak Dektol. stained with Giemsa, mounted with a glass coverslip. and observed microscopically with bright-field illumination."
MT2 cell line was used as a positive control and noninfected macrophages were used as the negative control.
Riwrse /ranscrip/a.w activiry assay. Reverse transcriptase activity (RT) was determined in the cell culture supematants as previously described.' Briefly, the supematants were ultracentrifugated (100.OOO rpm for 5 minutes; Beckmann TLIOO) and the viral pellets resuspended in 20 pL of NaCl 100 mmol/L, Tris-HCI IO mmol/L, pH 7.8, EDTA IO mmol/L (NTE) Triton X-100 0.1%. RT Reaction mixtures were incubated at 37°C for I hour and RT activity was quantified by measuring the incorporated radioactivity.
Monolayers of HTLV-I-infected or control macrophages were fixed on coverslips in 2.5% glutaraldehyde in 0.1 mol/L cacodylate buffer during 3 hours at +4T. The cells were subsequently scraped and post-fixed with 2% omnium tetroxide, dehydrated through a graded ethanol series. and embedded in epon.
Eleclron microscopv.
Ultrathin sections were stained with uranyl acetate and lead citrate and observed with a JEOL 100 CX I1 electron microscope (JEOL, Tokyo, Japan). An ultrastructural analysis of the MT2 cells was also performed as a control for assessing viral morphology. the HTLV-I-producing cell lines MT2 or C91/PL (Fig I) .
They appeared between day I5 and day 20 postinfection and were spontaneously lysed after 5 to 7 days, as indicative of a viral-induced cytopathogenic effect. These syncytia were not observed in control macrophage cultures or in mock-infected macrophages (MOLT4 cells). However, within the first days after the coculture, we always observed a macrophage activation and then round giant multinucleated cells. in both the MT2 and MOLT4 cocultures. These giant cells appeared also in control macrophage cultures, but in a significantly lower number. We did not observe any immortalization of the infected macrophages that died within 30 to 45 days. termine whether viral antigens were produced in these cells. immunofluorescence assays for viral proteins were performed. Cells reacted with anti-Env antibody both within the cytoplasm and on the cell surface (Fig 2) . Normal macrophages or mock-infected macrophages were never labeled with this antibody. HTLV-I antigens were not only observed in giant cells, but also in mono-or pauci-nucleated macrophages. To determine whether the HTLV-I-reactive cells were of macrophagic origin, we performed a double-immunostaining assay. AntLCD16 (anti-FcR 111). which does not label MT2 cells, reacted strongly with the HTLV-1 -positive cells (Fig  3) . whereas neither anti-CD4 nor antLCD25 labeling was observed (data not shown). The existence of the CD16+/ HTLV-I+ doubly positive cells indicated that the cells expressing viral antigens were macrophages. To examine whether viral retrotranscription had occurred in the infected macrophages, proviral DNA sequences were assessed by amplification of a DNA fragment (446 bp) of the HTLV-I env region, using the PCR method, in DNA extracted from macrophages at day 15 and day 2 I after infection. All DNA samples of infected macrophage cultures. derived from different normal donors, were positive (Fig 4) . Due to the lack of MT2 contaminants (see above), detection of HTLV-I env sequences results from an infection ofthe macrophages rather than from a carryover from the MT2 cells.
An active expression qf HTL V-I antigen occirrs in infected macropkage.y. The observation above indicated that viral replication may occur in the infected macrophages. To de-
Detection of a gene e.xpression in the infecled macrop1iage.s. ISH-positive signals were detected in nearly 10% of the infected macrophages at day I5 after infection. In our control experiments, we observed that the RNA-radiolabeled probe hybridized strongly to MT2 cells, but not to noninfected macrophages provided from the same donor (Fig 5) . Detection of matiire viral particle.y by electron microscopy. An electron microscopy analysis of infected macrophages, at day 35 postinfection. indicated the presence of type C virus-like particles. These retroviral elements were seen both within the cytoplasm ( 10% to 15% of the cells) and
Detection ofproviral DNA in cocirl[irrcd macrophages.
in the extracellular space. The morphology and the size (80 to I20 nm) of these structures were similar to HTLV-I virus, as described elsewhere' and as observed in the ultrastructural study of MT2 cells in our laboratory (Fig 6) . Moreover, retroviral membrane budding was observed with some of the extracellular particles. The ultrastructure analysis permitted the identification of macrophage morphology with an important vacuolar system. The multinucleated cells were numerous and the nuclei did not show the convoluted aspect of MT2 cells.
The macrophage infhion leads to infectiom viral particle prodirction as demonstrated hv transmission of HTLV-I to CBL. To determine whether infected macrophages produced infectious virus. they were overlayed with CBL at day 15 postinfection. After 48 to 72 hours of contact with the infected macrophages, CBL were harvested and cultured in separate flasks with IL-2-containing medium and passaged twice a week. The analysis of viral sequences was performed by PCR from day 2 to day 21 after infected macrophage contact (CBL culture growth index was 700 from end of coculture to day 2 I). A specific signal was obtained in all samples, the intensity of day 2 1 signal being identical to the day 2 one, making unlikely the possibility of an initial contamination by the nondividing macrophages (Fig 7) . Although the CBL were infected. neither immortalization nor IL-2-independent growth of the CBL was obtained after 3 weeks of culture. This is consistent with the delay of immortalization found by Del Mistro et al."
Despite an effective viral maturation, HTLV-1 production by macrophages was weak when reverse transcriptase activity was assessed in the culture supernatants (data not shown).
Sligma (?f virul production.
DISCUSS ION
Our results demonstrate that monocyte-derived macrophages are permissive in vitro to HTLV-I virus, allowing both viral transcription and replication. The detection of proviral DNA by PCR and the ISH detection of HTLV-I RNA allows us to affirm that both viral retrotranscription and gene expression occurred in the infected macrophages. Infection of macrophages leads to the production of mature and infectious particles as assessed by electron microscopy (EM) and by the viral transmission to the CBL. The process of infection by cellular contact between the target cells and the HTLV-I-producing cell line is commonly used and seems to be more efficient than cell-free transmis~ion.~-~~'* The irradiated MT2 or C91/PL cells did not persist in the culture and were not detected by morphologic. immunofluorescence, or electron microscopy studies. The observation of late syncytia. in favor of a cytopathogenic effect in the HTLV-Iinfected macrophages and not in the control cultures, argues rather for a virus-dependent process than for a nonspecific activation reaction. Although we detected proviral DNA using the PCR method. we are unable to affirm a proviral integration into the cellular genome without studies of the cell DNA by the Southern blot technique. Semiquantitative assay by scanning the autoradiography of the PCR allowed us to estimate the percentage of positive cells to be about 5%. Although we evaluated a weak viral load using viral DNA detection within the high molecular weight cellular DNA. the ISH and IF studies permitted the detection of a greater percentage of positive cells. This discordance might be linked to a significant amount of nonintegrated proviral DNA leading to viral cycle without genomic integration, as already shown with the HIV retrovirus. '3 The expression of HTLV-I -Env by the CDI 6+/CD25-cells (2 weeks after the initial infection) indicated that macrophages actively synthesized HTLV-I proteins. Furthermore, type C retrovirus-like particles were observed within the cytoplasm or in the extracellular spaces at day 35 from infection. All along the cultures, several stringent washes were always performed, indicating that these particles were synthesized by the macrophages. This excludes the persistence of virus coming from the MT2 cells in the supernatants. However, in contrast to the intensity of anti-Env expression, viral particles were less frequently observed in the cells (10% to 15% of the cells). This weak difference might be related to a low viral maturation rate as it has been frequently reported with infection by retr o v i r u s e~.~~
The HTLV-I cell receptor is not yet characterized, but is distinct from the CD4 molecule. It seems to be ubiquitous because numerous primary cell types, human or animal cell lines, are susceptible in vitro to HTLV-1.5'9 For example, HTLV-I can infect CD8+ T-cell line," B lymphocytes,x endothelial cells,' fibroblasts: or glial c e k 9 Furthermore. viral pseudotypes bearing HTLV-1 envelope glycoproteins are able to enter a variety of mammalian CD4-cell lines.'6 To gain entry into cultured macrophages, HTLV-I may recognize specific cell surface receptors or may be incorporated into a phagosome with cellular debris from irradiated MT2 cells. Although we do not know its route of entry into the macrophages, HTLV-I is able to productively infect these cells as indicated by retrotranscription, followed by a maturation cycle leading to replication and to infectious virus particle production.
Thus, human macrophages appear as a new primary cell type susceptible to HTLV-I in vitro infection, as suggested by several preliminary reports.".'* To our knowledge, although Richardson et a129 did not detect any HTLV-1 infection in blood monocytes of TSP patients, the susceptibility of macrophages has never been investigated ex vivo. If in vivo macrophage infection is demonstrated, we may expect that the susceptibility of the monocyte-macrophage lineage cells to HTLV-1 infection might explain several pathogenetical aspects of the disease. Particularly, the neurologic lesions in TSP/HAM patients might be related to macrophage infection. Although primary glial cells could be infected in vitro, the paucity of infected cells suggest a low susceptibility of this cell type for HTLV-I ? In addition, no evidence of HTLV-1 infection of such cells occurred ex vivo.3o On the other hand, a myelinotoxic activity in the colony-stimulating factor (CSF) of patients with HAM has been described by Osame et a14 and has been proposed as one mechanism of neural tissue damage." Infected macrophages may be able to secrete such cytopathic or neurotoxic substances leading to demyelination and secondary inflammatory processes. Numerous substances. such as proteases or cytokines (IL-I, IL-6, tumor necrosis factor [TNF]), may be released by infected macrophages or microglial cells through a nonspecific activation For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
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process or transactivation of their genes by viral proteins. Similar pathogenic effects were recently proposed for demyelination lesions in multiple sclerosis, in which a high TNF activity in the central nervous system (CNS) was observed in evolutive disease.32 In addition, neurologic lesions could be induced by a CD8' cytotoxic activity directed against CNSinfected macrophages. Indeed, a high level of circulating HTLV-I-specific cytotoxic T lymphocytes in patients with TSPIHAM, but not in ATLL, was reported by Jacobson et Additional investigations are needed to support the involvement and the role of infected macrophages in neural tissue injury.
In conclusion, we have shown that primary human macrophages are susceptible in vitro to HTLV-1 infection and replication. The ability for "fresh" HTLV-1 isolates to infect monocyte-macrophages may provide an approach for examining the monocytic tropism of different viral strains and for evaluating the macrophage role in the development of peculiar aspects of the HTLV-1 infection.
